As the world has focused on the COVID-19 pandemic, other microbial foes are waging war on humans. Antibiotic-resistant bacteria pose a growing threat. But viruses may defeat them.
Academic rigour, journalistic flair
Articles on CRISPR
Displaying 21 - 40 of 120 articles
We propose five principles that could guide a proper ethical and legal framework for germline editing and similar technologies.
Using ‘base editing’, researchers have cured progeria in mice. This genetic syndrome causes premature ageing in humans – those with the disease usually don’t live past the age of 13.
Canada has produced Nobel Prize winners in the arts and sciences. With several recent awards, Canadian talent still has the potential for future achievements.
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
Recent studies using CRISPR to fast-track genetic studies into human disease genes appear flawed.
New research involving CRISPR technology has furthered our understanding of corals’ gene functions. Specifically, it has revealed a mechanism underpinning how corals withstand heat stress.
Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel prize in chemistry for Crispr but they weren’t the only key figures in its development.
Jennifer Doudna and Emmanuelle Charpentier have been awarded the Nobel prize in Chemistry for their revolutionary work on ‘gene scissors’ that can edit DNA.
The tools to rewrite the genetic code to improve crops and livestock, or to treat genetic diseases, has revolutionized biology. A CRISPR engineer explains why this technology won the Nobel, and its potential.
Most scientific discoveries these days aren’t easily ascribed to a single researcher. CRISPR is no different – and ongoing patent fights underscore how messy research can be.
A new finding in mice rewrites the textbook explanation of the male sex-determining gene, Sry. It might also help us better understand how males and females come to be.
The immune system is trained to destroy viruses, even when they carry therapeutic cargo as is the case in gene therapy. Now researchers have figured out how to dial down the immune response.
A person dies of opioid overdose once every 13 minutes in the US. A researcher proposes a way using existing technology to remove the opioid target in people to prevent overdoses.
One of the methods researchers are exploring to combat COVID-19 is gene editing: altering the genome of the virus to make it harmless.
The debate about gene editing will help shape the future of the human race. But how should the discussion get started?
The scientist who announced the world’s first genome-edited twins received a prison sentence and a large fine for his research. But the systems that enabled him have not been held to account.
One year after the first CRISPR babies were announced, changes in policies and regulations have meant that there have been no new CRISPR announcements since.
A number of things may have gone wrong when researchers edited Chinese twins Lulu and Nana’s genome. Either way, the failed experiment is a cautionary tale for us all.
Ideas from economics might help us decide the most ethical way of using gene editing technology for human enhancement in the future.
Top contributors
-
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Associate professor, Queensland University of Technology
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Professor of Chemistry, Connecticut College
-
Doctoral Student in Biochemistry, University of Washington
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Research fellow, The University of Queensland
-
Director of Research and Professor of Pathology, Dalhousie University
-
Emeritus Professor of Developmental Biology, The University of Queensland
-
Research fellow, The University of Queensland
-
Postdoctoral Associate in Science and Society, Duke University
-
Postdoctoral fellow, Harvard University
